scholarly journals Does Duration of Symptoms Reliably Predict Detection of Left Atrial Thrombus in Newly Diagnosed Atrial Fibrillation

2021 ◽  
Vol 14 (2) ◽  
Author(s):  
Ali Sakhnini
Keyword(s):  
Atrial Fibrillation ◽  
Left Atrial ◽  
Newly Diagnosed ◽  
Left Atrial Thrombus ◽  
Atrial Thrombus ◽  
Duration Of Symptoms

scholarly journals Stroke or left atrial thrombus prediction using antithrombin III and mean platelet volume in patients with nonvalvular atrial fibrillation

2017 ◽  
Vol 40 (11) ◽  
pp. 1013-1019 ◽  
Author(s):  
Seo-Won Choi ◽  
Bo-Bae Kim ◽  
Dong-Hyun Choi ◽  
Geon Park ◽  
Byung Chul Shin ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Mean Platelet Volume ◽  
Left Atrial ◽  
Antithrombin Iii ◽  
Left Atrial Thrombus ◽  
Platelet Volume ◽  
Nonvalvular Atrial Fibrillation ◽  
Atrial Thrombus

scholarly journals NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world

2017 ◽  
Vol 249 ◽  
pp. 179-183 ◽  
Author(s):  
Emanuele Bertaglia ◽  
Matteo Anselmino ◽  
Alessandro Zorzi ◽  
Vincenzo Russo ◽  
Elisabetta Toso ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Real World ◽  
Left Atrial ◽  
Left Atrial Thrombus ◽  
Atrial Thrombus ◽  
The Real

scholarly journals Massive Left Atrial Thrombus in a Patient With Rheumatic Mitral Stenosis and Atrial Fibrillation While Anticoagulated With Dabigatran

2013 ◽  
Vol 6 (3) ◽  
pp. 491-492 ◽  
Author(s):  
Sushil Allen Luis ◽  
Karl Poon ◽  
Chris Luis ◽  
Akhil Shukla ◽  
Nicholas Bett ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Mitral Stenosis ◽  
Left Atrial ◽  
Left Atrial Thrombus ◽  
Atrial Thrombus ◽  
Rheumatic Mitral Stenosis

Abstract 12707: Chads2 and Chads2vasc Scores Predict the Risk for Left Atrial Thrombus in Patients With Atrial Fibrillation

Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
Fengpeng Jia ◽  
Minghuan Fu ◽  
Zhiyu Ling ◽  
Suxin Luo ◽  
Jun Gu ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Left Atrial ◽  
Strong Association ◽  
Anticoagulation Therapy ◽  
Scoring Systems ◽  
Left Atrial Thrombus ◽  
Atrial Thrombus ◽  
Chads2 Score ◽  
Risk Patients ◽  
The Relationship

Background: The study was to evaluate the value of CHADS2 and CHADS2VASC scores on predicting left atrial (LA) thrombus in the patients with atrial fibrillation (AF). Methods and Results: All the non-valvular AF patients undergoing AF ablation from June 2010 to June 2012 were included and divided into two groups: patients without anticoagulation and with Coumadin anticoagulation for at least 4 weeks. The relationship between CHADS2 and CHADS2VASC scores and LA thrombus as identified on transesophageal echocardiography (TEE) was analyzed prior to ablation. A total of 397 patients underwent pre-ablation TEE: 212 patients without anticoagulation, and 185 with anticoagulation. There were no differences in the CHADS2 and CHADS2VASC scores in the two groups. LA thrombus was present in 15.6% and 5.9% for the patients without anticoagulation and for those with anticoagulation, respectively (p = 0.002). There was a strong association between CHADS2 and LA thrombus, and between CHADS2VASC and LA thrombus in the two groups. No thrombus was identified in patients with CHADS2VASC score of 0 in both groups. However, thrombus was detected in 3.5% of patients with CHADS2 score of 0 in the group without anticoagulation, while no thrombus was present in the ones with anticoagulation. CHADS2VASC score of ≥1 (r=2.03, p = 0.04) was the only factor independently associated with LA thrombus in patients without anticoagulation, while both CHADS2VASC score of ≥2 (r=2.61, p=0.02) and CHADS2 score of ≥2 (r=2.73, p=0.01) were independently associated with LA thrombus. Further analyses showed that CHADS2VASC score was a better predictor for LA thrombus than CHADS2 score in patients without anticoagulation. However, there was no difference between the two scoring systems in predicting LA thrombus in patients with anticoagulation. Conclusions: LA thrombus was associated with CHADS2VASC and CHADS2 scores in non-valvular AF patients without anticoagulation. CHADS2VASC score was a better predictor than CHADS2 score for LA thrombus in patients without anticoagulation. The data suggested that it might be unnecessary to undergo a TEE evaluation for LA thrombus in low risk patients identified by CHADS2VASC score regardless anticoagulation therapy prior to cardioversion or ablation.

scholarly journals The Association of Interleukin 6−634C/G Polymorphism With Left Atrial Thrombus and Severe Spontaneous Echocontrast in Patients With Atrial Fibrillation

2012 ◽  
Vol 19 (6) ◽  
pp. 673-678 ◽  
Author(s):  
Xin-Tao Deng ◽  
Min-Hui Jiang ◽  
Jian-Hua Zhu ◽  
Li-Jun Ge ◽  
Jing Guo ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Interleukin 6 ◽  
Left Atrial ◽  
Left Atrial Thrombus ◽  
Atrial Thrombus

scholarly journals Evidence-Based Case Report: The Use of D-Dimer Assay to Exclude Left Atrial Thrombus in Patient with Atrial Fibrillation >48 Hours

2019 ◽  
Vol 11 (6) ◽  
Author(s):  
Raymond Pranata ◽  
Emir Yonas ◽  
Veresa Chintya ◽  
Alexander Edo Tondas ◽  
Sunu Budhi Raharjo
Keyword(s):  
Atrial Fibrillation ◽  
Case Report ◽  
Left Atrial ◽  
Evidence Based ◽  
Left Atrial Thrombus ◽  
Atrial Thrombus ◽  
D Dimer

Exclusion of left atrial thrombus by dual-source cardiac computed tomography prior to catheter ablation for atrial fibrillation

2018 ◽  
Vol 108 (2) ◽  
pp. 150-156 ◽  
Author(s):  
Marc Kottmaier ◽  
Clemens Jilek ◽  
Sophie Berglar ◽  
Tilko Reents ◽  
Felix Bourier ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Atrial Fibrillation ◽  
Catheter Ablation ◽  
Left Atrial ◽  
Cardiac Computed Tomography ◽  
Left Atrial Thrombus ◽  
Atrial Thrombus ◽  
Dual Source
Sign in / Sign up

Export Citation Format

Share Document